Citation only
via OpenAlex
Sirt1 as a New Therapeutic Target in Metabolic and Age-Related Diseases
Chonnam Medical Journal · 2010 · ▲ 14 citations
Abstract
Sirt1 among the mammalian sirtuins has generated intense scientific interest in recent years, mainly because of its effects on longevity, metabolism, and other aging-related processes. Via nicotinamide adenine dinucleotide (NAD)-dependent protein deacetylation, Sirt1 can regulate important metabolic regulators. Sirt1 is involved in insulin secretion in the pancreas, fatty acid oxidation in liver and skeletal muscle, hepatic gluconeogenesis during fasting, the suppression of fat storage in white adipose tissue, and the enhancement of insulin sensitivity in skeletal muscle. It also communicates with AMP-activated protein kinase (AMPK). Resveratrol, a prototype of Sirt1 activator, can induce similar changes reminiscent of caloric restriction(definition) in insulin-resistant obese rodent models, although clinical studies are still limited. Intensive research efforts are now targeting Sirt1 for pharmacologic interventions in aging and age-related metabolic and degenerative disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4068/cmj.2010.46.2.67
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Lee, D.H. (2010). Sirt1 as a New Therapeutic Target in Metabolic and Age-Related Diseases. <em>Chonnam Medical Journal</em>. https://doi.org/10.4068/cmj.2010.46.2.67
Vancouver
Lee DH. Sirt1 as a New Therapeutic Target in Metabolic and Age-Related Diseases. Chonnam Medical Journal. 2010. doi:10.4068/cmj.2010.46.2.67.
BibTeX
@article{dae2010Sirtas,
title = {Sirt1 as a New Therapeutic Target in Metabolic and Age-Related Diseases},
author = {Dae Ho Lee},
journal = {Chonnam Medical Journal},
year = {2010},
doi = {10.4068/cmj.2010.46.2.67},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Current Drug Targets 2013
Citation only
Sirtuins as Possible Drug Targets in Type 2 Diabetes
Aging 2012
Open access · CC-BY
The journey of resveratrol from yeast to human
University of Oregon 2017
Open access · US-GOV
Skeletal Muscle Myosin Binding Protein C in Fatigue and Aging
Signal Transduction and Targeted Therapy 2023
Open access · CC-BY
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
International Journal of Biological Sciences 2022
Open access · CC-BY
Novel Role of the SIRT1 in Endocrine and Metabolic Diseases
Cold Spring Harbor Perspectives in Biology 2011
Preprint · OA